ND jainn
Iron
- Joined
- May 22, 2026
- Posts
- 77
- Reputation
- 51
EXPLAINING
KY19382 – currently the most potent Wnt/β pathway activator, inhibiting the CXXC5 protein, which is responsible for the aging of growth plate cartilage during puberty. Inhibition of CXXC5 triggers rapi differentiation of longitudinal bone growth and slows the closure of growth plates by almost half. (which allows us to remove the restriction)
STUDY #1
The most interesting and important study was where KY19382 suppressed CXXC5 and activated Wnt/β-catenin.
In the same study, KY19382 showed an increase in tibia size with a dose of 0.1 mg/kg body weight. This is an incredible result and potential for height gain. A daily increase in the length of the growth plate.
It also affects COL2A1, RUNX2 and MMP13 in the growth plates.
STUDY #2
A functionally improved indirubin derivative, KY19382, elongated tibial length through delayed senescence and further activation of the growth plate in adolescent mice. Collectively, our findings reveal an important role for CXXC5 as a suppressor of longitudinal bone growth involving growth plate activity.
CONCLUSION
To sum it up, we can say with confidence that KY19382 Ideal for stack to increase bone length. It is very cheap (if you know where to buy) and extremely accessible.
The recommended dose is 705mcg/1g per kg of body weight.
As long as your growth plates are open, this will be the ideal option for increasing length.
KY19382 – currently the most potent Wnt/β pathway activator, inhibiting the CXXC5 protein, which is responsible for the aging of growth plate cartilage during puberty. Inhibition of CXXC5 triggers rapi differentiation of longitudinal bone growth and slows the closure of growth plates by almost half. (which allows us to remove the restriction)
STUDY #1
The most interesting and important study was where KY19382 suppressed CXXC5 and activated Wnt/β-catenin.
In the same study, KY19382 showed an increase in tibia size with a dose of 0.1 mg/kg body weight. This is an incredible result and potential for height gain. A daily increase in the length of the growth plate.
It also affects COL2A1, RUNX2 and MMP13 in the growth plates.
STUDY #2
A functionally improved indirubin derivative, KY19382, elongated tibial length through delayed senescence and further activation of the growth plate in adolescent mice. Collectively, our findings reveal an important role for CXXC5 as a suppressor of longitudinal bone growth involving growth plate activity.
CONCLUSION
To sum it up, we can say with confidence that KY19382 Ideal for stack to increase bone length. It is very cheap (if you know where to buy) and extremely accessible.
The recommended dose is 705mcg/1g per kg of body weight.
As long as your growth plates are open, this will be the ideal option for increasing length.
Attachments
Last edited:
